Lineage Announces Updates to 2nd Annual Spinal Cord Injury Investor Symposium

Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced updates to its 2nd Annual Spinal Cord Injury Investor Symposium ("2nd SCIIS"). The 2nd SCIIS aims...

Related Keywords

United States ,Miami ,Florida ,American ,Marco Baptista ,Michaela Kyle Devins ,Jerod Hanna Nieder ,Steven Kirshblum ,Jack Allen ,Joseph Pantginis ,Richardg Fessler ,Brianm Culley ,University Of Miami Miller School Medicine ,Lineage Cell Therapeutics Inc ,Eterna Therapeutics Inc ,Christopher Dana Reeve Foundation ,Rutgers New Jersey Medical School ,Product Service ,Senior Research Analyst ,Rw Baird Co Inc ,Department Of Neurosurgery ,Kessler Foundation ,Department Of Neurological Surgery ,Equity Research ,Roche Group ,Hc Wainwright Co Inc ,Genentech ,Exchange Commission ,University Medical Center ,Announces Updates ,Annual Spinal Cord Injury Investor ,Cell Therapeutics ,San Diego ,Medical Center ,Clinical Professor ,Neurological Surgery ,Miami Project ,Cure Paralysis ,Miami Miller School ,Chief Medical Officer ,Physical Medicine ,Chief Scientific Officer ,Dana Reeve Foundation ,Hanna Nieder ,Kyle Devins ,Managing Director ,Annual Spinal Cord Injury Investor Symposium ,Duane Roth Auditorium ,Sanford Consortium ,Regenerative Medicine ,Lineage Cell Therapeutics ,Eterna Therapeutics ,Annual Report ,Quarterly Report ,